Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-density lipoprotein subpopulations in pathologic conditions.

Bela F Asztalos1, Ernst J Schaefer

  • 1Atherosclerosis Research Laboratory, New England Medical Center, Boston, Massachusetts, USA. basztalos@hnrc.tufts.edu

The American Journal of Cardiology
|April 8, 2003
PubMed
Summary

High-density lipoprotein (HDL) subspecies, particularly large alpha and pre-alpha particles, are crucial for preventing coronary artery disease (CAD). Statins can shift HDL distribution toward normal, aiding in CAD risk reduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review.

Current atherosclerosis reports·2025
Same author

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi-Ethnic Study of Atherosclerosis: The Pooling Project.

Journal of the American Heart Association·2025
Same author

Lifestyle Modification in Prediabetes and Diabetes: A Large Population Analysis.

Nutrients·2025
Same author

Low-density lipoprotein cholesterol elevation, ketogenic diets, body mass index, and heterozygous ABCG5 genetic variation: Review, case report, and large population analysis.

Journal of clinical lipidology·2025
Same author

Diabetes Mellitus Risk Prediction in the Framingham Offspring Study and Large Population Analysis.

Nutrients·2025
Same author

High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk.

Nutrients·2025

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Molecular Biology

Background:

  • Low-density lipoprotein (LDL) cholesterol's role in coronary artery disease (CAD) is established, but high-density lipoprotein (HDL) cholesterol and its subspecies roles are less understood.
  • HDL particles, varying in size and density, are influenced by apolipoprotein (apo) A-I and lipid content.
  • Apo A-I-containing HDL particles facilitate cholesterol efflux via interactions with adenosine triphosphate-binding cassette transporter A1 (ABCA1).

Purpose of the Study:

  • To investigate the role of different high-density lipoprotein (HDL) subspecies in coronary artery disease (CAD).
  • To examine the impact of statins on HDL subspecies distribution in patients.

Main Methods:

  • Analysis of apo A-I-containing HDL subpopulations in Tangier disease patients (homozygous and heterozygous) and patients with low HDL or CAD.

Related Experiment Videos

  • Comparison of HDL subspecies distribution before and after statin therapy.

    • Main Results:

    • Tangier disease patients exhibit specific deficiencies in HDL subspecies (pre-beta(1) in homozygous, alpha- and pre-alpha in heterozygous).
    • Patients with low HDL or CAD show reduced levels of alpha(1) and pre-alpha(1-3) HDL subspecies.
    • Statins, particularly atorvastatin, increase large HDL subpopulations (alpha(1), pre-alpha(1)) and decrease small ones (alpha(3)), shifting distribution toward normal.

    Conclusions:

    • Specific HDL subspecies, especially larger ones, are vital for cholesterol efflux and preventing CAD.
    • Deficiencies in these HDL subspecies are linked to Tangier disease, low HDL levels, and CAD.
    • Statins effectively modulate HDL subspecies distribution, suggesting a therapeutic benefit in CAD management.